- Report
- October 2025
- 184 Pages
Global
From €3153EUR$3,545USD£2,774GBP
€3503EUR$3,939USD£3,082GBP
- Report
- October 2025
- 192 Pages
Global
From €3153EUR$3,545USD£2,774GBP
€3503EUR$3,939USD£3,082GBP
- Report
- October 2025
- 191 Pages
Global
From €3153EUR$3,545USD£2,774GBP
€3503EUR$3,939USD£3,082GBP
- Report
- March 2025
- 200 Pages
Global
From €2214EUR$2,490USD£1,948GBP
- Report
- August 2025
- 200 Pages
Global
From €2214EUR$2,490USD£1,948GBP
- Report
- May 2025
- 200 Pages
Global
From €2214EUR$2,490USD£1,948GBP
- Report
- May 2025
- 200 Pages
Global
From €2214EUR$2,490USD£1,948GBP
- Report
- March 2025
- 200 Pages
Global
From €2214EUR$2,490USD£1,948GBP
- Report
- October 2025
Global
From €4358EUR$4,900USD£3,834GBP
- Report
- August 2025
- 192 Pages
Global
From €3153EUR$3,545USD£2,774GBP
€3503EUR$3,939USD£3,082GBP
- Report
- October 2025
- 250 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Report
- October 2025
- 250 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Report
- October 2025
- 250 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Report
- October 2025
- 250 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Report
- October 2025
- 250 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Report
- September 2025
- 250 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Report
- September 2025
- 250 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Report
- September 2025
- 250 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Report
- September 2025
- 250 Pages
Global
From €3993EUR$4,490USD£3,513GBP
- Report
- September 2025
- 250 Pages
Global
From €3993EUR$4,490USD£3,513GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more